Oyler John's Form 4 filing
BeOne Medicines Ltd. (ONC) · filed Dec 29, 2022
- Accession no.
- 0001651308-22-000236
- Filed
- Dec 29, 2022
- Trade date
- Dec 27-29, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions. Open-market sales total $2.16M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oyler JohnCIK 0001042047 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2022 | American Depositary Shares | SSaleDisposed | −1,120 | $224.29F8 | −$251,204.8 | 0 | Direct | |
| Dec 27, 2022 | American Depositary Shares | SSaleDisposed | −1,120 | $224.29F8 | −$251,204.8 | 0 | Indirect | |
| Dec 27, 2022 | American Depositary Shares | SSaleDisposed | −1,119 | $224.29F8 | −$250,980.51 | 0 | Indirect | |
| Dec 28, 2022 | American Depositary Shares | SSaleDisposed | −367 | $224.73 | −$82,475.91 | 0 | Direct | |
| Dec 28, 2022 | American Depositary Shares | SSaleDisposed | −366 | $224.73 | −$82,251.18 | 0 | Indirect | |
| Dec 28, 2022 | American Depositary Shares | SSaleDisposed | −367 | $224.73 | −$82,475.91 | 0 | Indirect | |
| Dec 29, 2022 | American Depositary Shares | SSaleDisposed | −1,625 | $224.42F10 | −$364,682.5 | 91 | Direct | |
| Dec 29, 2022 | American Depositary Shares | SSaleDisposed | −91 | $225.13F11 | −$20,486.83 | 0 | Direct | |
| Dec 29, 2022 | American Depositary Shares | SSaleDisposed | −1,625 | $224.42F10 | −$364,682.5 | 92 | Indirect | |
| Dec 29, 2022 | American Depositary Shares | SSaleDisposed | −92 | $225.13F11 | −$20,711.96 | 0 | Indirect | |
| Dec 29, 2022 | American Depositary Shares | SSaleDisposed | −1,625 | $224.42F10 | −$364,682.5 | 92 | Indirect | |
| Dec 29, 2022 | American Depositary Shares | SSaleDisposed | −92 | $225.13F11 | −$20,711.96 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F8
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.00 to $224.76, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F10
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.00 to $224.94, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F11
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.02 to $225.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.